indirectly

Terapia Cluj indirectly held by Japanese firm

Through the acquisition of Ranbaxy, Daiichi has indirectly become a shareholder in Cluj-based drug maker Terapia, which derived turnover worth 91m euros in 2007. Daiichi Sankyo group, Japan's second largest drug producer with an annual turnover worth 5